These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15797300)

  • 1. In vivo 1H MR spectroscopy of thyroid carcinoma.
    King AD; Yeung DK; Ahuja AT; Tse GM; Chan AB; Lam SS; van Hasselt AC
    Eur J Radiol; 2005 Apr; 54(1):112-7. PubMed ID: 15797300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 T.
    King AD; Yeung DK; Ahuja AT; Yuen EH; Ho SF; Tse GM; van Hasselt AC
    Clin Radiol; 2005 May; 60(5):592-8. PubMed ID: 15851048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy as a diagnostic modality for carcinoma thyroid.
    Gupta N; Kakar AK; Chowdhury V; Gulati P; Shankar LR; Vindal A
    Eur J Radiol; 2007 Dec; 64(3):414-8. PubMed ID: 17462842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of optimal echo time for 1H-spectroscopic imaging of brain tumors at 3 Tesla.
    Hattingen E; Pilatus U; Franz K; Zanella FE; Lanfermann H
    J Magn Reson Imaging; 2007 Aug; 26(2):427-31. PubMed ID: 17654728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland tumors at in vivo proton MR spectroscopy.
    King AD; Yeung DK; Ahuja AT; Tse GM; Yuen HY; Wong KT; van Hasselt AC
    Radiology; 2005 Nov; 237(2):563-9. PubMed ID: 16244265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
    Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
    Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].
    Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ
    Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
    Qiu SJ; Zhang XL; Zhang Y; Jiang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma.
    King AD; Yeung DK; Ahuja AT; Leung SF; Tse GM; van Hasselt AC
    AJNR Am J Neuroradiol; 2004 Mar; 25(3):484-90. PubMed ID: 15037477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate, choline, and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer.
    Yokota H; Guo J; Matoba M; Higashi K; Tonami H; Nagao Y
    J Magn Reson Imaging; 2007 May; 25(5):992-9. PubMed ID: 17410583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR spectroscopy in multiple sclerosis.
    De Stefano N; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():31S-35S. PubMed ID: 17425732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region.
    El-Sayed S; Bezabeh T; Odlum O; Patel R; Ahing S; MacDonald K; Somorjai RL; Smith IC
    Head Neck; 2002 Aug; 24(8):766-72. PubMed ID: 12203802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral-maxillofacial malignant tumors: an initial study with in vivo single-voxel 1H MR spectroscopy].
    Yu Q; Wang PZ; Shi HM; Luo JC
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):18-20. PubMed ID: 17331436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.